Consolidated Statement Of Cash Flows

Immuno-Biological Laboratories Co., Ltd. - Filing #7616012

Concept 2021-04-01 to
2021-12-31
2020-04-01 to
2020-12-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-237,404,000 JPY
-299,965,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.